Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Natrix Separations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7534
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hydrogel structure that provides high density of binding sites and rapid mass transfer. Its HD-Q membrane adsorbers find application in single-use flow-through polish applications. Natrix supplies multi-cycle disposable chromatography products for life science, food, beverage and water markets. The company’s HD membrane technology offers breakthrough in membrane architecture that changes downstream purification. It markets its products through a network of distributors in Europe, North America and Asia. Natrix Separation is headquartered in Burlington, Ontario, Canada.

Natrix Separations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Acquisition 11
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc – Key Competitors 13
Natrix Separations Inc – Key Employees 14
Natrix Separations Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Natrix Separations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Natrix Separations Enters into Co-Development Agreement with Merck and Sanofi 9
Natrix Separations Enters into Co-Development Agreement with Scil Proteins 10
Merck to Acquire Natrix Separations 11
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 12
Natrix Separations Inc, Key Competitors 13
Natrix Separations Inc, Key Employees 14

List of Figures
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natrix Separations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saudi Electricity Co (5110):電力:M&Aディール及び事業提携情報
    Summary Saudi Electricity Co (SEC) is an energy utility. Through its subsidiaries, the company generates, transmits and distributes electricity; and carries out operations of the fiber optic networks, trading, realization of renewable energy, and other. It produces electricity in gas, combined, stea …
  • Ionis Pharmaceuticals, Inc.:企業のM&A・事業提携・投資動向
    Ionis Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ionis Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Kaleido Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kaleido Biosciences Inc (Kaleido Biosciences) is a developer of human microbiomes for the treatment of infectious, rare genetic, inflammatory, oncology and metabolic diseases. The company’s human microbiome is a metabolic engine which is developed from healthy and diseased humans using vario …
  • Menicon Co Ltd (7780)-医療機器分野:企業M&A・提携分析
    Summary Menicon Co Ltd (Menicon) is a medical device company that manufactures, export, import and markets ophthalmic products. The company’s products include soft contact lens, hard contact lens, astigmatic contact lens and bifocal contact lenses, among others. It offers contact lens care products …
  • Bank Alfalah Ltd:企業の戦略・SWOT・財務情報
    Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Alfalah Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Union Investment Group:企業の戦略・SWOT・財務情報
    Union Investment Group - Strategy, SWOT and Corporate Finance Report Summary Union Investment Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zenkyoren:企業の戦略・SWOT・財務情報
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Asian Infrastructure Investment Bank:電力:M&Aディール及び事業提携情報
    Summary Asian Infrastructure Investment Bank (AIIB) is a multilateral financial institution. The company develops infrastructure and other productive sectors. It provides sovereign and non-sovereign finance for sustainable projects in energy and power, transportation and telecommunications, rural in …
  • CEVA Holdings LLC:企業の戦略的SWOT分析
    CEVA Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BNC Bancorp:企業のM&A・事業提携・投資動向
    BNC Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BNC Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Catasys Inc (CATS):企業の財務・戦略的SWOT分析
    Summary Catasys Inc (Catasys) is a healthcare service provider that offers health and reducing claims costs for health plan members with behavioral health (BH) disorders. The company offers OnTrak, a fifty two week intensive outpatient program, treats an overlooked population and members suffering f …
  • Traverse Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an privately held bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company provides lead candidate TRB-N0224 which is dev …
  • Iconix Brand Group Inc (ICON):企業の財務・戦略的SWOT分析
    Iconix Brand Group Inc (ICON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Regency Centers Corporation:企業のM&A・事業提携・投資動向
    Regency Centers Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Regency Centers Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • TH Heavy Engineering Bhd (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Bhd (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kazanorgsintez (KZOS):企業の財務・戦略的SWOT分析
    Kazanorgsintez (KZOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Brinker International, Inc.:企業の戦略・SWOT・財務情報
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Baoding Lightway Green Energy Technology Co Ltd:企業の戦略的SWOT分析
    Baoding Lightway Green Energy Technology Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆